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Randomized comparison of cold blood and cold
crystalloid renal perfusion for renal protection
during thoracoabdominal aortic aneurysm repair
Scott A. LeMaire, MD, Marisa M. Jones, BS, Lori D. Conklin, MD, Stacey A. Carter, BA,
Monique D. Criddell, BS, Xing Li Wang, MD, PhD, Steven A. Raskin, CCP, and
Joseph S. Coselli, MD, Houston, Tex
Objective: More effective adjuncts are needed to reduce the incidence of acute renal injury after thoracoabdominal aortic
aneurysm (TAAA) repair. The purpose of this randomized trial was to determine whether renal perfusion with cold blood
provides better protection against renal ischemia than perfusion with cold crystalloid in patients undergoing TAAA repair
with left heart bypass.
Methods:One hundred seventy-two patients were enrolled. Strict inclusion criteria were used, including planned Crawford
extent II or III TAAA repair with left heart bypass. The patients were randomly assigned to receive intermittent renal
perfusion with either 4°C lactated Ringer’s solution (n 86) or 4°C blood (n 86). Renal complications within 10 days
of operation were stratified by renal dysfunction score (RDS). Postoperative changes in the levels of five urinary
biomarkers—retinol binding protein, -1 microglobulin, microalbumin, N-acetyl--D-glucosaminidase, and intestinal
alkaline phosphatase—were compared to assess potential differences in subclinical renal injury.
Results: Although total ischemic times were longer in the cold blood group, unprotected ischemic times were similar
between the two groups. Twenty-seven patients in the cold blood group (31%) and 21 patients in the cold crystalloid
group (24%) had peak RDS >2 (serum creatinine >50% above baseline; P  .4). There were no differences between the
cold blood and cold crystalloid groups in the incidence of early death (7/86 [8%] vs 5/86 [6%], respectively; P  .8) or
renal failure requiring hemodialysis (3/86 [3%] in both groups). Changes in renal biomarker levels were also similar in
the two groups. Spinal cord deficits developed in 5 patients in the cold blood group (6%); there were no such deficits in
the cold crystalloid group (P  .06).
Conclusion: Cold renal perfusion during TAAA repair provides effective protection against renal injury. Using cold blood
instead of cold crystalloid does not enhance renal protection. (J Vasc Surg 2009;49:11-9.)Although many advances have been made in organ pro-
tection during thoracoabdominal aortic aneurysm (TAAA)
repair, renal injury continues to be a major complication of
this operation and a chief contributor to postoperative
morbidity and mortality.1-5 Several techniques have been
tried in an attempt to decrease renal complications, includ-
ing various methods of renal perfusion.6-9 Our previous
randomized clinical trial10 compared two renal perfusates:
cold crystalloid fluid (lactated Ringer’s solution) and iso-
thermic blood from the left heart bypass (LHB) circuit. The
results showed that patients who received intermittent cold
crystalloid perfusion had a significantly lower incidence of
renal dysfunction than patients who received continuous
isothermic blood perfusion.We concluded that the benefits
of cold-crystalloid-induced renal hypothermia—including
decreased metabolic demand and reduced ischemic tissue
damage—outweighed the benefits of providing oxygen,
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perfusion. We then reasoned that combining these two
modalities, ie, perfusing the kidneys with cold blood in-
stead of cold crystalloid, could capitalize on their respective
advantages and provide superior renal protection. There-
fore, we conducted a randomized trial to determine
whether perfusion with cold blood is more effective than
perfusion with cold crystalloid in preventing renal compli-
cations in patients undergoing TAAA repair.
METHODS
Study design. The primary study question was whether
patients who receive cold blood perfusion have a lower
incidence of postoperative renal dysfunction than patients
who receive cold crystalloid. Postoperative renal function
was evaluated by using the renal dysfunction score (RDS),
as defined by Kashyap et al4 and used in our previous
study.10 To determine the study sample size, a power
analysis was performed that was based on two assumptions
derived from our previous trial:10 first, that 21% of patients
in the cold crystalloid group would develop peak RDS2;
and second, that, if effective, the use of cold blood would
reduce the incidence of renal dysfunction by two-thirds.
From these assumptions, we determined that approxi-
mately 86 patients would be needed in each group to
achieve 80% power with   .05.
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Medicine Institutional Review Board, and written in-
formed consent was obtained from all enrolled patients.
From Jan 2002 to Dec 2006, all patients requiring surgical
repair of TAAAs were evaluated for entry into the study.
The study group was limited to patients in whomCrawford
extent II or III TAAA repairs using LHB were planned.11
(We use LHB routinely in extent II repairs, but only very
selectively in extent III repairs.) Preoperative exclusion
criteria included planned extent I or IV repairs, planned
repair without LHB, need for hypothermic circulatory ar-
rest (HCA), prior TAAA repair, pseudoaneurysm, free aor-
tic aneurysm rupture, inability to monitor left kidney tem-
perature, impaired renal function (defined as renal failure
requiring dialysis or serum creatinine 3 mg/dL), im-
paired left ventricular function (defined as ejection fraction
20%), liver disease (defined as conjugated bilirubin 0.3
mg/dL), age younger than 18 years, and inability to obtain
consent. Blocked randomization was used to assign en-
rolled patients to receive either cold crystalloid or cold
blood renal perfusion; patients were assigned in a 1:1 ratio
and in blocks of 20. The surgical team was not blinded to
Fig 1. Flow of study patients. HCA, hypothermic circ
TAAA, thoracoabdominal aortic aneurysm. *Some patiethe treatment assignment. All enrolled patients wereblinded to the assigned perfusion strategy and were in-
cluded in the intent-to-treat analysis. Intraoperative exclu-
sion criteria applied after randomization included change in
the extent of aortic replacement to descending thoracic or
extent I or IV TAAA repair; LHB not being used; inability
to use heparin; and inability to selectively perfuse the kid-
neys. Because post-randomization exclusion could intro-
duce bias, randomized patients who received their assigned
treatment were included in a separate efficacy analysis.
Patients. During the study period, TAAA repairs were
planned in 738 patients, of whom 384 (52%) were to
undergo extent II or III repairs (Fig 1). Two hundred
twelve of these patients were excluded from enrollment
because the planned repair was to be made without LHB
(118 patients); the patient refused to participate, or staff
could not otherwise obtain consent (27); the patient had
prior TAAA repair (22), liver disease (20), preoperative
renal failure (8), rupture (7), or age younger than 18 years
(1); left kidney temperature could not be monitored be-
cause of large cysts, severe atrophy, or prior nephrectomy
(16); or HCA was necessary (3). (Some patients had more
than one reason for exclusion.) Thus, 172 patients met
ry arrest; LHB, left heart bypass; OR, operating room;
et more than one exclusion criterion.ulatopreoperative inclusion criteria and provided informed con-
sed fo
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perfusion group, and 86 patients (50%) were randomized
to the cold crystalloid perfusion group. These random
assignments were strictly adhered to, ie, there was no
crossover between treatment groups. Seventeen random-
ized patients were excluded in the operating room because
LHB was not used (8 patients), the extent of the repair was
changed (8), the kidneys could not be selectively perfused
(1), or heparin could not be used (1). Therefore, 155
patients received the assigned treatment: 77 received cold
blood, and 78 received cold crystalloid.
Perfusion systems. Our standard LHB circuit in-
cluded a 26F right-angled cannula (LifeStream Interna-
tional, Inc, TheWoodlands, Tex) to drain blood via the left
inferior pulmonary vein, a centrifugal pump (Biomedicus,
Medtronic, Inc, Minneapolis, Minn), a return line with a
20F right-angled cannula (LifeStream International) for
the distal aorta, and a second return line with two 9F Pruitt
balloon perfusion catheters (Ideas for Medicine, St Peters-
burg, Fla) to deliver blood to the celiac and superior
mesenteric arteries. The circuit did not include a heat
exchanger or oxygenator.
Cold blood perfusion was delivered by a modified LHB
circuit (Fig 2) that included separate visceral and renal
return lines comprising Intersept Cardioplegia table lines
(Medtronic Cardiopulmonary Division, Anaheim, Calif), a
reservoir, a roller pump, and a cooling coil in ice. The
visceral and renal return lines each terminated in two 9F
Pruitt balloon perfusion catheters. The circuit was primed by
gravity with 800 mL of lactated Ringer’s solution, 450 mL of
which was directed into the renal perfusion limb. After LHB
was initiated, approximately 300 mL of blood was pumped
Fig 2. Diagram illustrating the circuit uinto the renal circuit reservoirwhile the initial crystalloid primewas flushed out. Mannitol (1.25 g per 100 mL blood) and
methylprednisolone (12.5mgper 100mLblood)were added
to the reservoir. A recirculation line allowed continuous cool-
ing of the blood to 4°C. The roller pump was used to deliver
an initial 300 mL of cold blood to the renal arteries at a flow
rate of 100 to 150 mL/minute (mean perfusion pressure was
171  67 mm Hg). After each bolus infusion, the renal
reservoir was refilled with blood from the circuit (along with
additional mannitol and methylprednisolone) as needed to
prepare for the subsequent bolus.
Cold crystalloid perfusion was delivered from a perfusion
system separate from the standard LHB circuit. The circuit
consisted of a cardiotomy reservoir with ¼-inch tubing going
through a roller head pump. The perfusate was lactated Ring-
er’s solution with mannitol (12.5 gm/L) and methylpred-
nisolone (125mg/L) cooled to 4°C. An initial bolus infusion
(400-600 mL) of the solution was instilled into the renal
arteries, followed by additional intermittent infusions (100-
200 mL) until arterial flow was re-established.
Surgical procedure. The surgical technique used for
TAAA repair in our practice has been described in detail
recently.12,13 While the necessary exposure of the thoraco-
abdominal aorta was obtained, the patient’s body temper-
ature was allowed to drift downward to 32°C to 34°C. A
myocardial temperature probe (18-mm Mon-a-therm,
Mallinckrodt Medical, Hazelwood, Miss) was inserted into
the parenchyma of the left kidney. After 1 mg/kg of
heparin was administered, the left pulmonary vein and
supraceliac aorta were cannulated, and LHBwas initiated at
a flow of 500 mL/minute. The proximal and distal aortic
cross-clamps were placed, and the LHB flows were in-
creased to 2000 mL/minute. The aortic segment isolated
r delivering cold blood renal perfusion.between the two clamps was opened longitudinally, and a
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mal aortic end. After the proximal anastomosis was com-
pleted, LHB was discontinued and the distal cross-clamp
was removed. The remaining aneurysm was then opened
longitudinally to expose the visceral arterial ostia. The celiac
and superior mesenteric perfusion catheters were inserted to
provide continuous perfusion with isothermic blood from the
LHB circuit at an average flow rate of 400 mL/minute. The
two renal perfusion catheters were placed in the renal arteries
to allow intermittent perfusion with either 4°C blood or
crystalloid. In patients with accessory renal arteries, only the
primary artery to each kidney was perfused.
Systemic and left kidney temperatures were monitored
throughout the aortic reconstruction period. The amount
of cold perfusate delivered was based on a balance between
achieving renal hypothermia (target left kidney tempera-
ture,15°C; Fig 3), avoiding excessive systemic hypother-
mia (target body temperature, 32-34°C), and, in the crys-
talloid group, avoiding fluid overload (indicated by mean
pulmonary artery pressure 30 mm Hg). The intercostal
and visceral arteries were then reattached. The choice of
technique for renal artery reattachment was based on the
anatomy of the visceral vessels. In 54 patients (31%), a
single patch containing the origins of all four visceral vessels
was reattached to an opening in the side of the graft. One or
both renal arteries were reattached separately as buttons in
60 patients (35%). Dacron interposition grafts were used to
reattach one or both renal arteries in 52 patients (30%).
Once the visceral arteries were reattached, the balloon
perfusion catheters were removed, and the distal anastomo-
sis was completed. The aortic clamp was removed, and
protamine sulfate was given to reverse the heparin. Intra-
venous indigo carmine was administered, and its urinary
clearance time was recorded. Diuretics were commonly
administered after unclamping. Gradual, partial rewarming
was facilitated by irrigating the operative field with warm
saline. No patients received aprotinin.
Sample collection and analysis. Serum creatinine lev-
els were obtained at baseline and daily on postoperative days
1 through 10. Urine samples were obtained after induction
of anesthesia, after indigo carmine clearance, and on post-
operative days 1, 2, 3, and 7. Five mL of urine was collected
in vials containing 0.25 mL stabilizing buffer. These vials
were stored at -80°C until analysis, which was completed
at the University of Antwerp in Belgium. Five urinary
biomarkers—retinol binding protein (RBP), -1 micro-
globulin, microalbumin, N-acetyl--D-glucosaminidase
(NAG), and intestinal alkaline phosphatase (IAP)—were
evaluated. A latex immunoassay was used to analyze RBP;
this involved incubating the urine samples with antibody-
coated particles and measuring the agglutination with a cell
counter. Both -1 microglobulin and microalbumin mark-
ers were evaluated by using immunonephelometry (Dade
Behring, Brussels, Belgium), and NAG was determined by
colorimetric assay (Roche Diagnostics, Basel, Switzerland).
The enzyme-antigen immunoassay was used to analyze
IAP. This test was done with microtiter plates treated with
anti-IAP antibody. Assay dilute was added to the wells,followed by urine samples. After incubation, the wells were
rinsed, a substrate solution was added, and absorption at
405 nm was measured. All biomarkers were indexed to
urinary creatinine, which was tested by the colorimetric
Jaffé method and an alkaline picrate reaction to measure
creatinine concentrations. All urine samples were analyzed
in duplicate. For each biomarker, we determined the peak
postoperative level, the difference between peak postoper-
ative and baseline levels, and the proportion of patients in
whom levels increased to 30% or more above baseline.
Statistical analysis. Categorical variables were ana-
lyzed with two-tailed Fisher exact tests and reported as
number (and proportion) of patients. Continuous variables
were presented as mean  standard deviation; those with
normal distributions were analyzed with t tests, whereas
variables with skewed distributions were analyzed with
Wilcoxon rank-sum tests. All statistical analyses were per-
formed with the SPSS 15.0 software package (SPSS Inc,
Chicago, Ill).
RESULTS
The two groups were very similar with regard to demo-
graphics and baseline laboratory and urinary marker values
(Table I). The cold blood group had a higher proportion of
patients with preoperative serum creatinine levels 1.5
mg/dL than the cold crystalloid group (20% vs 9%), but
Fig 3. Representative pattern of change in left kidney temperature
during intermittent cold perfusion. This patient received cold blood
during an extent III thoracoabdominal aortic repair. Arrows indicate
delivery of a cold blood bolus to both renal arteries; the volume
infused is indicated above each arrow. Seven boluses (100-300 mL
each) were given, providing a total renal perfusion volume of 1300
mL. The initial left kidney temperature was 32.6°C. After perfusion,
kidney temperature ranged from 12.5°C to 20.0°C.this difference did not reach statistical significance (P 
et for
Renal
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only 14 (8%) underwent extent III repair (Table II). Most
repairs were elective (n 150, 87%). There were significant
differences in several total ischemic times, with the cold
blood group having longer ischemia times for the intercos-
tal arteries, the right and left legs, and the right renal artery.
All unprotected ischemic times, however, were similar be-
tween groups. Although the perfusate volume fell within
the desired range (600-1800 mL), we were only able to
achieve intraoperative renal temperatures below 15°C in
37% of all patients. However, the two perfusion techniques
were similarly effective in achieving satisfactory levels of
renal hypothermia (Table III); left kidney temperature
reached 20°C in 112 of the 155 patients (72%) who
received cold perfusion, and deep hypothermia (defined as
28°C) was achieved in nearly all patients. Despite a mean
lowest body temperature of 32.1°C, only 4 patients had
intraoperative dysrhythmias (2%); all 4 had atrial fibrilla-
tion, and 1 also had transient ventricular tachycardia (at
30°C) that resolved after lidocaine administration.
The intent-to-treat analysis revealed no differences in
renal outcomes between the two groups (Table IV). Twenty-
seven patients in the cold blood group (31%) and 21
patients in the cold crystalloid group (24%) had peak RDS
2 (serum creatinine 50% above baseline; P  .4). Sim-
ilarly, 12 patients in the cold blood group (14%) and 10
Table I. Comparison of preoperative characteristics
Preoperative variables Overall gro
Age (years) 62.5
Male gender 106
Ideal body weight (kg)a 77.6
Hypertension 147
Diabetes 14
Smoking history (past or current) 137
Peptic ulcer disease 15
Intravenous contrast (within 48 hrs) 18
Acetylcysteine 7
Aortic dissection
Acute dissection 2
Subacute dissection 6
Chronic dissection 71
Acute and chronic dissections 2
Left renal artery occlusive disease 33
Right renal artery occlusive disease 34
Accessory renal arteries 4
Baseline serum creatinine (mg/dL) 1.1
Baseline serum creatinine 1.5 25
Creatinine clearance (mL/minute) 63.7
Glomerular filtration rate (mL/minute/1.73m2)b 67.9
Baseline urinary marker levels
Creatinine (g) 138.2
IAP (U/g Cr) 3.6
NAG (U/g Cr) 6.6
Microalbumin (mg/g Cr) 108.4
RBP (g/g Cr) 75.3
1 microglobulin (mg/g Cr) 17.0
Cr, Urinary creatinine; IAP, intestinal alkaline phosphatase; NAG, N-acety
aIdeal body weight was estimated as 50 kg  2.3 kg for each inch over 5 fe
bGlomerular filtration rate was calculated using the Modification of Diet inpatients in the cold crystalloid group (12%) had peak RDS3 (serum creatinine 100% above baseline; P  .8), and
only 3 patients in each group (3%) had peak RDS 5 (renal
failure requiring hemodialysis). Changes in renal injury
biomarker levels (relative to baseline) were also similar in
the two groups (Table IV), as were the absolute peak
biomarker levels and the proportion of patients who had a
30% increase in biomarker levels (data not presented).
There were no differences between the cold blood and cold
crystalloid groups in the incidence of early death (7/86
[8%] vs 5/86 [6%], respectively; P  .8). Whereas 5 pa-
tients (6%) in the cold blood group experienced postoper-
ative paraplegia or paraparesis, no patients in the cold
crystalloid group experienced this adverse event (P  .06).
The efficacy analysis, which only included the 155 patients
who received the assigned treatment, confirmed the simi-
larities in renal outcomes in the two groups (data not
presented). Among the 25 patients in the subgroup who
had preoperative serum creatinine levels1.5mg/dL, only
2 (8%) had peak RDS 3; both patients were in the cold
blood group (2/17 [12%] vs 0/8; P  1.0).
The degree of hypothermia achieved did not affect
renal outcomes. Peak RDS 2 occurred in 17 of the 64
patients (27%) in whom the left renal temperature target of
15°C was reached and in 31 of the 108 patients (29%) in
whom the target temperature was not reached (P  .9).
Similarly, peak RDS 3 occurred in 9 of the 64 patients
 172) Blood (n  86) Crystalloid (n  86) P value
.8 60.7  13.6 64.2  11.7 .07
) 56 (65%) 50 (58%) .6
.0 79.3  32.2 76.0  20.8 .2
) 74 (86%) 73 (85%) 1.0
6 (7%) 8 (9%) .8
) 64 (74%) 73 (85%) .4
8 (9%) 8 (9%) 1.0
) 10 (12%) 8 (9%) .8
5 (6%) 2 (2%) .5
1 (1%) 1 (1%) 1.0
4 (5%) 2 (2%) .7
) 39 (45%) 32 (37%) .4
0 2 (2%) .5
) 14 (16%) 19 (22%) .5
) 17 (20%) 17 (20%) 1.0
2 (2%) 2 (2%) 1.0
3 1.2  0.4 1.1  0.3 .1
) 17 (20%) 8 (9%) .08
.3 63.7  26.4 63.9  26.4 1.0
.1 67.3  22.5 68.6  19.7 .7
.4 142.0  76.1 134.5  84.7 .5
0 3.4  6.2 3.7  7.7 .8
.0 7.1  11.8 6.2  10.3 .6
8.5 114.6  266.0 102.1  272.4 .8
.9 65.8  27.3 84.8  42.9 .7
.8 14.7  18.9 19.2  59.1 .5
glucosaminidase; RBP, retinol binding protein.
men and 45.5 kg  2.3 kg for each inch over 5 feet for women.
Disease equation.14up (n
 12
(62%
 27
(85%
(8%)
(80%
(9%)
(10%
(4%)
(1%)
(3%)
(41%
(1%)
(19%
(20%
(2%)
 0.
(15%
 26
 21
 80
 7.
 11
 26
 35
 43
l--D-(14%) in whom the left renal temperature reached 15°C
Table II. Comparison of intraoperative variables
Intraoperative variables
Overall group
(n  172)
Blood
(n  86)
Crystalloid
(n  86) P value
Extent of repaira
Extent II repair 158 (92%) 82 (95%) 76 (88%) .2
Extent III repair 14 (8%) 4 (5%) 10 (12%) .2
Renal artery reattachment technique
Single patch 54 (31%) 27 (31%) 27 (31%) 1.0
Single separate renal attachment 46 (27%) 22 (26%) 24 (28%) .9
Single renal interposition graft 33 (19%) 15 (17%) 18 (21%) .7
Single beveled distal anastomosis 13 (8%) 8 (9%) 5 (6%) .6
Bilateral renal interposition grafts 12 (7%) 7 (8%) 5 (6%) .8
Bilateral separate renal attachments 7 (4%) 2 (2%) 5 (6%) .4
One separate renal attachment  one renal interposition graft 7 (4%) 5 (6%) 2 (2%) .4
Urgency of repair
Elective 150 (87%) 75 (87%) 75 (87%) 1.0
Urgent 17 (10%) 9 (10%) 8 (9%) 1.0
Emergent 5 (3%) 2 (2%) 3 (3%) 1.0
Cerebrospinal fluid drainage 157 (91%) 81 (94%) 76 (88%) .7
Total aortic cross-clamp time (minutes) 71.1  24.4 74.4  27.7 67.8  20.8 .08
Total cross-clamp time 100 minutes 14 (8%) 9 (10%) 5 (6%) .4
Left heart bypass time (minutes) 25.1  10.1 25.6  9.5 24.6  10.8 .5
Intercostal ischemic times (minutes)
Total ischemic timeb 57.3  14.3 60.0  9.5 54.8  13.7 .02
Unprotected ischemic timec 37.0  12.1 37.9  13.0 36.0  11.2 .3
Celiac ischemic times (minutes)
Selective perfusion time 19.8  10.2 20.0  9.2 19.5  10.7 .8
Total ischemic timeb 61.5  14.9 62.6  14.3 60.4  15.5 .3
Unprotected ischemic timec 40.8  11.6 40.7  12.5 40.9  10.8 .9
Superior mesenteric ischemic times (minutes)
Selective perfusion time 19.7  10.0 20.3  9.1 19.2  10.8 .5
Total ischemic timeb 61.4  14.7 62.6  14.1 60.3  15.3 .3
Unprotected ischemic timec 40.7  11.5 40.7  12.3 40.8  10.6 .9
Right leg ischemic times (minutes)
Total ischemic timeb 64.6  20.1 67.8  23.2 61.4  15.9 .04
Unprotected ischemic timec 43.8  18.1 45.8  22.7 41.9  11.7 .2
Left leg ischemic times (minutes)
Total ischemic timeb 64.3  18.7 67.2  21.0 61.5  15.7 .04
Unprotected ischemic timec 45.2  25.4 48.3  33.8 42.0  11.6 .1
Right renal ischemic times (minutes)
Total ischemic timeb 61.8  14.8 64.0  14.6 59.5  14.7 .05
Unprotected ischemic timec 41.1  11.7 42.0  12.9 40.2  10.3 .3
Left renal ischemic times (minutes)
Total ischemic timeb 66.3  20.0 68.9  20.5 63.7  18.4 .08
Unprotected ischemic timec 45.7  16.8 46.8  19.1 44.6  14.0 .4
Total renal ischemic time  60 minutesb 31 (18%) 17 (20%) 14 (16%) .7
Left kidney temperature (°C)
Baseline temperatured 33.0  2.2 33.1  2.4 33.0  1.9 .7
Lowest temperature 16.9  6.1 17.4  6.8 16.5  5.4 .4
Left kidney temperature  15°C 64 (37%) 33 (38%) 31 (36%) .9
Nasopharyngeal temperature (°C)
Baseline temperatured 34.2  1.0 34.2  1.1 34.2  1.0 .6
Lowest temperature 32.1  1.2 32.2  1.0 32.0  1.2 .2
Last recorded temperature 32.9  0.9 33.0  0.8 33.0  1.0 .9
Total renal perfusion time (minutes) 7.6  3.1 8.2  3.4 6.9  2.8 .01
Total renal perfusion volume (mL) 1001.0  531.3 1037.0  687.6 966.1  319.1 .4
Urine output during operation (mL) 1165.3  775.6 1148.9  808.7 1181.4  746.6 .8
Urine indigo carmine clearance time (minutes) 21.4  20.6 20.9  16.6 22.0  24.0 .7
Transfusion requirements (U)
Packed red blood cells 3.5  3.2 3.5  2.5 3.4  3.7 .9
Fresh frozen plasma 6.7  5.5 6.7  5.7 6.7  5.3 1.0
Cryoprecipitate 2.5  7.6 3.4  8.9 1.5  5.9 .1
Post-clamp diuretics administered 157 (91%) 82 (95%) 75 (87%) .5
Intraoperative dysrhythmias 4 (2%) 1 (1%) 3 (3%) .6
aThe classification of TAAAs followed the schema defined by Crawford et al.11 Extent II repairs involved graft replacement of most of the thoracoabdominal
aorta, usually beginning near the left subclavian artery and extending into the infrarenal aorta. Extent III repairs only replaced the lower descending thoracic
aorta (ie, below the sixth rib) and extended a variable distance into the abdominal aorta.
bTotal ischemic time was defined as the time from aortic clamping to removal of the clamp and reinstitution of blood flow to the region.
cUnprotected ischemic time was defined as total ischemic time minus left heart bypass time.
dBaseline nasopharyngeal and left kidney temperatures were recorded before the aorta was clamped.
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temperature was not reached (P  .8).
DISCUSSION
Previously, most strategies for renal protection during
TAAA surgery employed either hypothermia or blood per-
fusion. The protective effects of renal hypothermia are well
established.15-17 In contrast, perfusion with isothermic
blood does not seem to be as effective as hypothermia10
and may actually increase the risk of renal injury.18 How-
ever, perfusion with blood does offer several potential
benefits, including delivery of oxygen and buffers, preven-
tion of cell membrane damage, and reduction of intracel-
lular swelling. Like various techniques described by other
groups,8,19-23 the use of cold blood in this randomized trial
was an attempt to combine the benefits of hypothermia and
blood perfusion, in the hope of further reducing the inci-
dence of renal dysfunction. The perfusion system we inves-
tigated delivered blood to the kidneys, achieved deep renal
hypothermia (28°C), maintained acceptable systemic
temperatures without active warming, and was incorpo-
rated into a standard LHB circuit. Nonetheless, our find-
ings did not support our hypothesis that cold blood is more
effective than cold crystalloid in preventing renal complica-
tions in patients undergoing TAAA repair. We acknowl-
edge that changes in delivery technique, such as using
continuous perfusion instead of intermittent perfusion,
might make cold blood perfusion more effective.
Although we used a target left kidney temperature of
15°C to guide perfusion during the study, the data show
that this target is frequently not reachable within the con-
straints of avoiding fluid overload and severe systemic hy-
pothermia. More importantly, based on the post hoc com-
parison of patients who reached the 15°C target with those
who did not, temperatures between 15°C and 28°C appear
to be as effective as temperatures below 15°C, suggesting
that it is not necessary to achieve profound renal hypother-
mia to provide renal protection.
Our primary outcome was based on the postoperative
RDS, which quantifies the severity of renal dysfunction by
comparing baseline and peak serum creatinine levels. When
compared to using renal failure requiring hemodialysis as
an endpoint, RDS is more sensitive in detecting postoper-
ative renal complications, which allows a much smaller
sample size. However, changes in serum creatinine occur
well after renal injury has occurred, making RDS relatively
insensitive in detecting renal parenchymal damage. For this
reason, we used urinary biomarkers as indicators of subclin-
Table III. Effectiveness of achieving renal hypothermia
Lowest left kidney
temperature
Overall group
(n  155)
Blood
(n  77)
Crystalloid
(n  78)
P
value
15°C 64 (41%) 33 (43%) 31 (40%) .7
20°C 112 (72%) 53 (69%) 59 (76%) .4
28°C 151 (97%) 75 (97%) 76 (97%) 1.0ical renal injury.24 Several studies have examined the use ofurinary biomarkers to detect renal injury associated with
cardiovascular operations.25-27 The urinary markers used in
the present study—RBP, -1 microglobulin, microalbu-
min, NAG, and IAP—were selected because they were
known to be effective in detecting renal injury when this
study was initiated.28-34 Since the start of our study, several
new biomarkers—such as neutrophil gelatinase-associated
lipocalin, kidney injury molecule-1, and cysteine-rich pro-
tein 61—have surfaced35-37 and merit consideration for
evaluating renal function in future trials.
Several limitations of this study warrant discussion.
First, the potential for cold blood to provide renal protec-
tion by delivering oxygen, nutrients, and buffers to the
ischemic kidney is entirely theoretical. We have not studied
these properties in 4°C blood, but we recognize that cold
temperatures shift the oxyhemoglobin dissociation curve to
the left, reducing the blood’s ability to release oxygen. Nev-
ertheless, cold blood perfusion is widely used in cardiac sur-
gery to prevent ischemic complications, both as a component
of blood cardioplegia for myocardial protection and as the
perfusate used for selective antegrade cerebral perfusion dur-
ing operations requiring HCA. Furthermore, several centers
have used cold blood perfusion to provide renal protec-
tion.8,19-21,23 It was this clinical precedence that stimulated us
to formally compare cold blood with cold crystalloid.
Second, although the study groups were well-matched
in most areas, the cold blood group had longer total
ischemic times and a trend toward a higher incidence of
spinal cord deficit, even though unprotected ischemic times
were similar in both groups. The reason for the difference in
total ischemic times is not clear, because there were no
substantial differences in the frequency of aortic dissection,
the extent of repair, or the urgency of operation. Nor were
there significant differences in body temperature, the prev-
alence of diabetes, or the use of cerebrospinal fluid drain-
age, factors known to affect the risk of spinal cord injury.38
Of note, our risk model for predicting paraplegia rates in
groups undergoing TAAA repair estimated equivalent risks
(10%) for the two groups.39
Third, we did not collect data related to pulmonary
complications. These data would have been valuable, given
that the use of cold crystalloid (vs re-infusion of the patient’s
cooled blood) involved infusing, on average, nearly 1 liter of
fluid. Although this infusion of additional crystalloid was not
associated with an increase in length of hospital stay, we
cannot determine whether the increase in fluid administration
translated into more pulmonary complications.
Finally, we were not able to use the recently established
RIFLE classification system for acute renal injury,40 which
uses both glomerular filtration rate (GFR) criteria and urine
output criteria to place patients in Risk, Injury, Failure,
Loss, and End-stage kidney disease categories. Our study
was designed and initiated before RIFLE became well
established. Consequently, although we collected daily
postoperative urine output data, we did not collect the
hourly urine output data needed to determine RIFLE class.
However, it is notable that if the RIFLE GFR criteria are
applied to our patients, the Risk category corresponds to an
-D-gl
k post
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Injury category corresponds to an RDS of 3 (doubling in
creatinine vs baseline). Nevertheless, future studies of renal
protection during TAAA repair would benefit by using
RIFLE classification as an endpoint.
Despite these limitations, this randomized trial shows
that using cold renal perfusion during TAAA repair pro-
vides effective protection against renal injury, but using
cold blood instead of cold crystalloid does not enhance
renal protection. In light of these results, we currently use
cold crystalloid renal perfusion, which is somewhat less
cumbersome than the cold blood technique. Future studies
will evaluate the efficacy of combining cold crystalloid
perfusion with other renal protection strategies.
The study was supported by the Gillson Longenbaugh
Foundation and the Baylor College of Medicine Junior
Faculty Seed Funding Program (SAL). The authors wish to
thank Shirong Chang, MD, Elizabeth Farley, Stephanie
Kreml, MD, Anne Laux, George Pisimisis, MD, Lindsey
Rudloff, Shixang Wen, and Jonathan Wilks, MD, for assis-
tance with data and sample collection; Patrick C. D’Haese,
PhD, and Marc E. De Broe, MD, PhD, in the Department
of Nephrology-Hypertension at the University of Antwerp
in Belgium for performing renal marker assays; Terry
Crane, CCP, for invaluable assistance with our perfusion
system; Stephen N. Palmer, PhD, ELS, for editorial assis-
tance; and Scott A. Weldon, MA, CMI, for creating the
illustrations.
AUTHOR CONTRIBUTIONS
Conception and design: SL, LC, SR, JC
Analysis and interpretation: SL, MJ, XW, JC
Table IV. Comparison of outcomes
Outcomes Overall group (n  172)
Peak serum creatinine (mg/dL) 1.7  1.0
Increase in urinary marker levelsa
Creatinine (g) 84.8  73.5
IAP (U/g Cr) 6.5  17.4
NAG (U/g Cr) 36.0  214.4
Microalbumin (mg/g Cr) 367.4  1777.1
RBP (g/g Cr) 39.1  75.7
1 microglobulin (mg/g Cr) 150.5  160.9
Postoperative dopamine infusion 140 (81%)
Peak RDS
1 124 (72%)
2 26 (15%)
3 13 (7%)
4 3 (2%)
5 6 (3%)
Average daily urine output (mL) 2126.6  1961.9
Paraplegia/paraparesis 5 (3%)
Hospital length of stay (days) 15.7  12.7
Operative mortality 12 (7%)
In-hospital mortality 10 (6%)
30-day mortality 10 (6%)
Cr, urinary creatinine; IAP, intestinal alkaline phosphatase;NAG,N-acetyl-
aIncreases in biomarker levels were calculated as the difference between peaData collection: MJ, SC, LC, MCWriting the article: SL, MJ, MC, XW, SR
Critical revision of the article: SL, MJ, SC, LC, XW, SR, JC
Final approval of the article: SL, MJ, SC, LC, MC, XW,
SR, JC
Statistical analysis: SL, MJ, XW
Obtained funding: SL, LC, JC
Overall responsibility: SL, JC
REFERENCES
1. Schepens M, Dossche K, Morshuis W, Heijmen R, van Dongen E, ter
Beek H, et al. Introduction of adjuncts and their influence on changing
results in 402 consecutive thoracoabdominal aortic aneurysm repairs.
Eur J Cardiothorac Surg 2004;25:701-7.
2. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286
thoracoabdominal aortic aneurysms. Ann Thorac Surg 2007;83:
S862-4.
3. Miller CC III, Villa MA, Achouh P, Estrera AL, Azizzadeh A, Coogan
SM, et al. Intraoperative skeletal muscle ischemia contributes to the risk
of renal dysfunction following thoracoabdominal aortic repair. Eur
J Cardiothorac Surg 2008;33:691-4.
4. Kashyap VS, Cambria RP, Davison JK, L’Italien GJ. Renal failure after
thoracoabdominal aortic surgery. J Vasc Surg 1997;26:949-55.
5. Hagiwara S, Saima S, Negishi K, Takeda R, Miyauchi N, Akiyama Y,
et al. High incidence of renal failure in patients with aortic aneurysms.
Nephrol Dial Transplant 2007;22:1361-8.
6. Leijdekkers VJ, Wirds JW, Vahl AC, van Genderingen HR, Siebenga J,
Westerhof N, et al. The visceral perfusion system and distal bypass
during thoracoabdominal aneurysm surgery: an alternative for physio-
logical blood flow? Cardiovasc Surg 1999;7:219-24.
7. Hassoun HT, Miller CC III, Huynh TT, Estrera AL, Smith JJ, Safi HJ.
Cold visceral perfusion improves early survival in patients with acute
renal failure after thoracoabdominal aortic aneurysm repair. J Vasc Surg
2004;39:506-12.
8. Okamoto H, Fujimoto K, Tamenishi A, Niimi T. Alternate venous
drainage and return of warmed blood combined with continuous hy-
pothermic visceral perfusion: a new adjunct of thoracoabdominal aortic
Blood (n  86) Crystalloid (n  86) P value
1.7  0.9 1.7  1.1 .7
82.5  73.6 86.7  73.9 .7
8.0  23.6 5.1  6.8 .3
52.5  300.9 19.4  29.3 .3
537.2  2485.5 195.5  283.9 .2
39.3  74.0 38.8  77.9 1.0
160.6  189.6 140.3  125.6 .4
70 (81%) 70 (81%) 1.0
59 (69%) 65 (76%) .6
15 (17%) 11 (13%) .5
8 (9%) 5 (6%) .6
1 (1%) 2 (2%) 1.0
3 (3%) 3 (3%) 1.0
2128.7  1796.5 2124.6  2121.8 1.0
5 (6%) 0 .06
15.7  10.3 15.7  14.7 1.0
7 (8%) 5 (6%) .8
6 (7%) 4 (5%) .7
6 (7%) 4 (5%) .7
ucosaminidase;RBP, retinol binding protein;RDS, renal dysfunction score.
operative levels and baseline levels.aneurysm repair. Jpn J Thorac Cardiovasc Surg 2001;49:94-8.
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 1 LeMaire et al 199. Rehring TF, Hollis HW Jr. Supraceliac aortic shunting for maintenance
of antegrade renal perfusion during complex aortic reconstruction.
J Am Coll Surg 2003;196:657-60.
10. Köksoy C, LeMaire SA, Curling PE, Raskin SA, Schmittling ZC,
Conklin LD, et al. Renal perfusion during thoracoabdominal aortic
operations: cold crystalloid is superior to normothermic blood. Ann
Thorac Surg 2002;73:730-8.
11. Crawford ES, Crawford JL, Safi HJ, Coselli JS, Hess KR, Brooks B,
et al. Thoracoabdominal aortic aneurysms: preoperative and intraoper-
ative factors determining immediate and long-term results of operations
in 605 patients. J Vasc Surg 1986;3:389-404.
12. Coselli JS, LeMaire SA. Tips for successful outcomes for descending
thoracic and thoracoabdominal aortic aneurysm procedures. Semin
Vasc Surg 2008;21:13-20.
13. Coselli JS, LeMaire SA. Descending and thoracoabdominal aortic an-
eurysms. In: Cohn LH, editor. Cardiac surgery in the adult. 3rd ed.
New York: McGraw-Hill; 2008. p. 1277-98.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more
accurate method to estimate glomerular filtration rate from serum
creatinine: a new prediction equation. Modification of Diet in Renal
Disease Study Group. Ann Intern Med 1999;130:461-70.
15. Levy MN. Oxygen consumption and blood flow in the hypothermic,
perfused kidney. Am J Physiol 1959;197:1111-4.
16. Semb G, Krog J, Johansen K. Renal metabolism and blood flow during
local hypothermia, studied bymeans of renal perfusion in situ. Acta Chir
Scand Suppl 1960;253:196-202.
17. Moyer JH. The effect of hypothermia on renal function and renal
damage from ischemia. Ann N Y Acad Sci 1959;80:424-34.
18. SafiHJ, Harlin SA,Miller CC III, Iliopoulos DC, Joshi A,Mohasci TG,
et al. Predictive factors for acute renal failure in thoracic and thoraco-
abdominal aortic aneurysm surgery. J Vasc Surg 1996;24:338-44.
19. Yamashita C, OkadaM, Ataka K, Yoshida M, Nohara H, Azami T, et al.
Surgical results for thoraco-abdominal aneurysm by modified DeBakey
method using centrifugal biopump and renal cryopreservation. J Car-
diovasc Surg (Torino) 1998;39:399-404.
20. Safi HJ, Winnerkvist A, Miller CC III, Iliopoulos DC, Reardon MJ,
Espada R, et al. Effect of extended cross-clamp time during thoracoab-
dominal aortic aneurysm repair. Ann Thorac Surg 1998;66:1204-9.
21. Cinà CS, Irvine KP, Jones DK. A modified technique of atriofemoral
bypass for visceral and distal aortic perfusion in thoracoabdominal aortic
surgery. Ann Vasc Surg 1999;13:560-5.
22. Moriyama Y, Yotsumoto G, Hisatomi K, Matsumoto H, Toda R,
KaiedaM. Thoracoabdominal aortic aneurysms repair under abdominal
cavity cooling with visceral shunting technique—a case report. Vasc
Surg 2001;35:229-32.
23. Fehrenbacher J, Siderys H, Shahriari A. Preservation of renal function
utilizing hypothermic circulatory arrest in the treatment of distal tho-
racoabdominal aneurysms (types III and IV). Ann Vasc Surg 2007;21:
204-7.
24. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighi-
ouart H, et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and
kidney injury molecule-1 level are associated with adverse outcomes in
acute renal failure. J Am Soc Nephrol 2007;18:904-12.
the topic of this study, I wonder if you could give us your data25. Cressey G, Roberts DR, Snowden CP. Renal tubular injury after infra-
renal aortic aneurysm repair. J Cardiothorac Vasc Anesth 2002;16:
290-3.
26. Faulí A, Gomar C, Campistol JM, Alvarez L, Manig AM, Matute P.
Pattern of renal dysfunction associated with myocardial revasculariza-
tion surgery and cardiopulmonary bypass. Eur J Anaesthesiol 2003;20:
443-50.
27. Loef BG, Epema AH, Navis G, Ebels T, van Oeveren W, Henning RH.
Off-pump coronary revascularization attenuates transient renal damage
compared with on-pump coronary revascularization. Chest 2002;121:
1190-4.
28. Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR. Assessment of
urinary retinol-binding protein as an index of proximal tubular injury.
Clin Chem 1987;33:775-9.
29. Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA, MacLen-
nan IC. Alpha-1-microglobulin: an indicator protein for renal tubular
function. J Clin Pathol 1983;36:253-9.
30. Davey PG, Gosling P. 2-Microglobulin instability in pathological
urine. Clin Chem 1982;28:1330-3.
31. Nakamura S, Yoshihara F, Kamide K, Nakahama H, Nishigami K,
Fukuchi K, et al. Microalbuminuria and deterioration of renal function
after elective repair of infrarenal abdominal aortic aneurysm. Clin Neph-
rol 2006;65:165-72.
32. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, et al.
Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular
cell dysfunction and a predictor of outcome in primary glomerulone-
phritis. Nephrol Dial Transplant 2002;17:1890-6.
33. Nouwen EJ, De Broe ME. Human intestinal versus tissue-nonspecific
alkaline phosphatase as complementary urinarymarkers for the proximal
tubule. Kidney Int Suppl 1994;47:S43-51.
34. Chew SL, Lins RL, Daelemans R, Nuyts GD, De Broe ME. Urinary
enzymes in acute renal failure. Nephrol Dial Transplant 1993;8:507-11.
35. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al.
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for
acute renal injury after cardiac surgery. Lancet 2005;365:1231-8.
36. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney
Injury Molecule-1 (KIM-1): a novel biomarker for human renal proxi-
mal tubule injury. Kidney Int 2002;62:237-44.
37. Muramatsu Y, Tsujie M, Kohda Y, Pham B, Perantoni AO, Zhao H,
et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in
urine following renal ischemic reperfusion injury. Kidney Int 2002;
62:1601-10.
38. Coselli JS, LeMaire SA,Miller CC III, Schmittling ZC, Pagan J, Köksoy
C, et al. Mortality and paraplegia after thoracoabdominal aortic aneu-
rysm repair: a risk factor analysis. Ann Thorac Surg 2000;69:409-14.
39. LeMaire SA, Miller CC III, Conklin LD, Schmittling ZC, Coselli JS.
Estimating groupmortality and paraplegia rates after thoracoabdominal
aortic aneurysm repair. Ann Thorac Surg 2003;75:508-13.
40. Arnaoutakis GJ, Bihorac A, Martin TD, Hess PJ Jr, Klodell CT, Ejaz
AA, et al. RIFLE criteria for acute kidney injury in aortic arch surgery.
J Thorac Cardiovasc Surg 2007;134:1554-60.Submitted Jun 4, 2008; accepted Aug 19, 2008.DISCUSSION
Dr Richard Cambria (Boston, Mass). Congratulations on a
well-conducted and obviously exhaustively detailed study. I think
you’ve shown, and it’s always nice to see, data that reinforces one’s
bias that cold crystalloid perfusion, of course, can be a very effective
means of renal protection during these extensive operations. And
my major question was detailed on your slide that your data
showed that the renal ischemic times are really identical between
the two.
Of course, we also know that the patients with baseline
abnormal renal function are those that are at the highest risk for
perioperative renal dysfunction. So I certainly agree with the
conclusions and the tenets of your study. And although it’s notor thoughts on cold renal protection in those with baseline renal
insufficiency.
Dr Coselli. Absolutely, it was not the intent of this particular
evaluation to determine whether one technique was superior over
another in patients with preoperative renal dysfunction. In fact, as
I showed, impaired renal function was an exclusion criterion for
this specific randomized trial.
However, off the cuff (and leaning more towards opinion but
somewhat away from speculation), just based on experience, we
have employed cold crystalloid perfusion in patients with preoper-
ative renal dysfunction and have found it to be quite favorable; but
we haven’t analyzed it in a rigorous statistical way, so it nowhere
near approaches Level 1 data.
